Paraneoplastic and Cancer Treatment-Related Rheumatic Disorders, An Issue of Rheumatic Disease Clinics, 1st Edition
Authors :
Kenneth J. Scalapino & Charles R. Thomas JR
Date of Publication: 01/2012
This issue of Rheumatic Disease Clinics of North America provides foundational and in-depth information about paraneoplastic and cancer treatment-related rheumatic disorders, in which every practicing rheumatologist should be well-versed. Topics cov ...view more
This issue of Rheumatic Disease Clinics of North America provides foundational and in-depth information about paraneoplastic and cancer treatment-related rheumatic disorders, in which every practicing rheumatologist should be well-versed. Topics covered include neoplasm risk in patients with rheumatic diseases; neoplasm risk of anti-rheumatic therapy; rheumatologic laboratory findings in malignancy; rheumatic manifestations of primary and metastatic bone tumors and paraneoplastic bone disease; neoplastic/paraneoplastic synovitis; neoplastic/paraneoplastic dermatitis, fasciitis, and panniculitis; neoplastic/paraneoplastic vasculitis, vasculopathy, and hypercoagulability; neoplastic/paraneoplastic myalgias and myositis; and less-common neoplastic/paraneoplastic syndromes.
This issue of Rheumatic Disease Clinics of North America provides foundational and in-depth information about paraneoplastic and cancer treatment-related rheumatic disorders, in which every practicing rheumatologist should be well-versed. Topics covered include neoplasm risk in patients with rheumatic diseases; neoplasm risk of anti-rheumatic therapy; rheumatologic laboratory findings in malignancy; rheumatic manifestations of primary and metastatic bone tumors and paraneoplastic bone disease; neoplastic/paraneoplastic synovitis; neoplastic/paraneoplastic dermatitis, fasciitis, and panniculitis; neoplastic/paraneoplastic vasculitis, vasculopathy, and hypercoagulability; neoplastic/paraneoplastic myalgias and myositis; and less-common neoplastic/paraneoplastic syndromes.
Author Information
By Kenneth J. Scalapino, MD, Section Chief, Rheumatology
Hospital Road
Portland, OR and Charles R. Thomas JR, MD, Professor & Chairman, Dept. of Radiation Medicine, Oregon Health and Sciences University Knight Cancer Institute, Portland Oregon
https://www.uk.elsevierhealth.com/paraneoplastic-and-cancer-treatment-related-rheumatic-disorders-an-issue-of-rheumatic-disease-clinics-9781455711895.html85193Paraneoplastic and Cancer Treatment-Related Rheumatic Disorders, An Issue of Rheumatic Disease Clinicshttps://www.uk.elsevierhealth.com/media/catalog/product/9/7/9781455711895_6.jpg69.3472.99GBPInStock/Medicine and Surgery/Rheumatology/Books/Clinics Review Articles100535255039561283917453100005145120This issue of Rheumatic Disease Clinics of North America provides foundational and in-depth information about paraneoplastic and cancer treatment-related rheumatic disorders, in which every practicing rheumatologist should be well-versed. Topics covered include neoplasm risk in patients with rheumatic diseases; neoplasm risk of anti-rheumatic therapy; rheumatologic laboratory findings in malignancy; rheumatic manifestations of primary and metastatic bone tumors and paraneoplastic bone disease; neoplastic/paraneoplastic synovitis; neoplastic/paraneoplastic dermatitis, fasciitis, and panniculitis; neoplastic/paraneoplastic vasculitis, vasculopathy, and hypercoagulability; neoplastic/paraneoplastic myalgias and myositis; and less-common neoplastic/paraneoplastic syndromes. This issue of Rheumatic Disease Clinics of North America provides foundational and in-depth information about paraneoplastic and cancer treatment-related rheumatic disorders, in which every practicing rheumatologist should be well-versed. Topics covered include neoplasm risk in patients with rheumatic diseases; neoplasm risk of anti-rheumatic therapy; rheumatologic laboratory findings in malignancy; rheumatic manifestations of primary and metastatic bone tumors and paraneoplastic bone disease; neoplastic/paraneoplastic synovitis; neoplastic/paraneoplastic dermatitis, fasciitis, and panniculitis; neoplastic/paraneoplastic vasculitis, vasculopathy, and hypercoagulability; neoplastic/paraneoplastic myalgias and myositis; and less-common neoplastic/paraneoplastic syndromes.00add-to-cart97814557118952012ProfessionalBy Kenneth J. Scalapino, MD and Charles R. Thomas JR, MD20111Book152w x 229h (6.00" x 9.00")Saunders016 Jan 2012PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 10 DAYSBy <STRONG>Kenneth J. Scalapino</STRONG>, MD, Section Chief, Rheumatology
Hospital Road
Portland, OR and <STRONG>Charles R. Thomas JR</STRONG>, MD, Professor & Chairman, Dept. of Radiation Medicine, Oregon Health and Sciences University Knight Cancer Institute, Portland OregonClinicsThe Clinics: Internal MedicineNoNoNoNoPlease SelectPlease SelectPlease Select